Patrick Ruz
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
- Oncology 4
- HER2/EGFR in Cancer Research 2
- CAR-T cell therapy research 2
- Co-authors
- Daniel Addison (13 shared papers)Farrukh T. Awan (3 shared papers)Eric D. Miller (3 shared papers)Jennifer A. Woyach (3 shared papers)Sujay Kalathoor (2 shared papers)Michael R. Grever (3 shared papers)Adam S. Kittai (3 shared papers)Seema A. Bhat (3 shared papers)
- Journals
- Blood (2 papers)JAMA Oncology (1 paper)American Journal of Veterinary Research (1 paper)Journal of Clinical Oncology (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesEgypt
In The Last Decade
Patrick Ruz
13 papers receiving 162 citations
Peers
Comparison fields: 5 of 50
- Genetics 54
- Hematology 36
- Cardiology and Cardiovascular Medicine 64
- Pathology and Forensic Medicine 37
- Oncology 53
Countries citing papers authored by Patrick Ruz
This map shows the geographic impact of Patrick Ruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Ruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Ruz more than expected).
Fields of papers citing papers by Patrick Ruz
This network shows the impact of papers produced by Patrick Ruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Ruz. The network helps show where Patrick Ruz may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Ruz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 48 | |
| 2 | 2022 | 46 | |
| 3 | 2022 | 21 | |
| 4 | 2024 | 13 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 4 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 1 |
About Patrick Ruz
Patrick Ruz is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 13 papers that have together received 164 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cardiac Imaging and Diagnostics (3 papers), HER2/EGFR in Cancer Research (2 papers), CAR-T cell therapy research (2 papers), Neuroblastoma Research and Treatments (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Genetics (54 citations), Hematology (36 citations), Cardiology and Cardiovascular Medicine (64 citations), Pathology and Forensic Medicine (37 citations) and Oncology (53 citations). Patrick Ruz has collaborated with scholars based in United States and Egypt. Frequent co-authors include Daniel Addison, Farrukh T. Awan, Eric D. Miller, Jennifer A. Woyach, Sujay Kalathoor, Michael R. Grever, Adam S. Kittai, Seema A. Bhat, Tracy Wiczer and Qiuhong Zhao. Their work appears in journals such as Blood, JAMA Oncology, American Journal of Veterinary Research, Journal of Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.